Methamphetamine Addiction: Health, Family and Treatment
Author: Ian C. Langtree - View Credentials
Published: 4 Sep 2009 - Updated: 12 Oct 2026
Publication Type: Submitted Article
Table of Contents:
Synopsis - Definition - Overview - FAQs - Insights, Updates - Related Content
Synopsis
This information reviews methamphetamine addiction in the United States, drawing on federal survey, overdose and drug enforcement data along with National Institute on Drug Abuse research to show who is affected and why it matters. About 2.4 million Americans aged 12 or older used methamphetamine in 2024, and overdose deaths involving the drug class fell to 28,722 that year. Today's supply has shifted from small home labs to cheaper, more potent cartel-made methamphetamine from Mexico. The article explains the risks to children and unborn babies, the long-term effects on the brain and body, and how far recovery can go with sustained abstinence. It is a practical resource for families, caregivers, child welfare workers and people with disabilities or chronic health conditions who want reliable, current information about methamphetamine and its treatment.
At a Glance
- 1 - Long-term methamphetamine use raises the risk of stroke, which can cause permanent brain damage.
- 2 - Some state Medicaid programs, including California, Montana and Washington, now cover contingency management.
- 3 - Methamphetamine-related psychosis, including paranoia and hallucinations, can last for months or years after use stops.
- 4 - Children exposed to methamphetamine before birth may show motor delays as toddlers. Subtle but significant attention and behavior problems can appear by school age.
Topic Definition
- Methamphetamine Use Disorder
Methamphetamine use disorder is a chronic, treatable medical condition in which a person keeps using methamphetamine despite harm to their health, relationships, work or family life. Methamphetamine is a synthetic central nervous system stimulant that floods the brain with dopamine, producing intense euphoria, alertness and energy that are followed by a crash and strong cravings. Over time, repeated use changes brain systems that control reward, decision-making and self-control, leading to tolerance, withdrawal symptoms and compulsive use. The condition is diagnosed by a health professional based on its pattern and severity, and it is treated mainly with behavioral therapies such as contingency management and cognitive behavioral therapy.
Overview
Methamphetamine is a powerful, highly addictive stimulant that changes how the brain handles dopamine, the chemical tied to pleasure, motivation and movement. In the United States its use is no longer a new trend. It is a long-running public health problem that affects users, their families and especially their children. Health agencies, child welfare workers and addiction specialists have spent years studying how the drug takes over a person's private, professional and social life, and what helps people recover.
How Many People Use Methamphetamine
The 2024 National Survey on Drug Use and Health estimated that about 2.4 million Americans aged 12 or older, or 0.8 percent, used methamphetamine in the past year. That level did not change significantly between 2021 and 2024 [Substance Abuse and Mental Health Services Administration, 2025]. The 2022 survey estimated that 1.8 million people had a methamphetamine use disorder. Among people with a substance use disorder, those with methamphetamine use disorder were the most likely to have a moderate or severe form, at 60.2 percent [Office of National Drug Control Policy, 2025].
Overdose deaths remain high. In 2024, 28,722 people in the United States died from overdoses involving psychostimulants with abuse potential, a category made up mainly of methamphetamine. That was down from 34,855 deaths in 2023, and the age-adjusted death rate fell by 19.8 percent [Garnett and Minino, 2026].
Where Methamphetamine Comes From Today
In the early 2000s much of the country's methamphetamine was cooked in small, portable labs in homes, motel rooms and vehicles, using cold medicines bought over the counter. That changed after the Combat Methamphetamine Epidemic Act was signed in 2006. The law moved pseudoephedrine products behind the pharmacy counter, set daily purchase limits and required buyers to show photo ID and sign a logbook [Congressional Research Service, 2008].
Production then shifted to Mexico, where cartels make methamphetamine with the P2P method from less tightly controlled chemicals. The Drug Enforcement Administration reports that U.S. lab seizures fell from 23,700 in 2004 to only 60 in 2023. It describes today's cartel-made methamphetamine as more potent and cheaper than at any other time in the past decade [Drug Enforcement Administration, 2024].
Comparing Methamphetamine and Cocaine Users
A 2006 paper for the National Center on Substance Abuse and Child Welfare, written by Cathleen Otero, Sharon Boles, Nancy K. Young and Kim Dennis, compared people who use methamphetamine with people who use cocaine. It reported that methamphetamine users tended to start younger and enter treatment at an earlier age. They were more likely to use several drugs, used more often and spread their use across the day. They were also more likely to be women and white [Otero et al., 2006].
Effects on Children and Pregnancy
The same paper warned that children of parents with methamphetamine addiction are often chronically neglected and face a greater risk of abuse. It also found that parents who used methamphetamine were less likely than parents using cocaine or heroin to understand the risks to an unborn child [Otero et al., 2006]. Children living where the drug is used or made may be exposed to toxic chemicals. Reported effects include coughing, breathing problems, skin irritation and chemical burns.
Research supports concern about prenatal exposure. Using methamphetamine during pregnancy has been linked to preterm delivery, placental abruption and low birth weight. A large NIDA-funded study followed exposed children over time. It found poorer movement quality and higher stress in infancy, motor delays at ages 1 and 2, and subtle but significant attention, thinking and behavior problems by school age [National Institute on Drug Abuse, n.d.-b].
To protect children, many communities have set up Drug Endangered Children (DEC) teams. These teams bring together law enforcement, child welfare, medical and treatment professionals. Expanded treatment for parents gives families a better chance of staying together or reuniting safely.
Long-Term Health Effects and Recovery
Long-term use can cause anxiety, confusion, insomnia, mood swings, violent behavior and psychosis. The psychosis can include paranoia and hallucinations and may last for months or years after use stops. Physical effects include weight loss, severe tooth decay and skin sores. Use also raises the risk of stroke, which can cause permanent brain damage [National Institute on Drug Abuse, n.d.-a].
There is real reason for hope, but recovery is partial rather than complete. Brain imaging studies show that some changes ease with long-term abstinence. Dopamine transporter levels can approach normal after about two years, and some brain regions recover after 14 months without the drug. Other brain changes, however, last much longer and may not fully return to normal [National Institute on Drug Abuse, n.d.-a].
Treatment That Works
Behavioral therapies are the most effective treatments for methamphetamine addiction. These include cognitive behavioral therapy and contingency management, which gives people rewards for staying in treatment and testing drug-free. The Matrix Model is a 16-week program that combines counseling, family education, drug testing and 12-step support, and it has been shown to reduce methamphetamine use [National Institute on Drug Abuse, n.d.-c]. Some state Medicaid programs, including California, Montana and Washington, now cover contingency management [Office of National Drug Control Policy, 2025].
No medication has yet been approved by the Food and Drug Administration for methamphetamine use disorder [Office of National Drug Control Policy, 2025]. Research is ongoing. In a trial published in the New England Journal of Medicine, 13.6 percent of participants given injectable naltrexone plus oral bupropion responded to treatment, compared with 2.5 percent on placebo. That benefit was real but modest [Trivedi et al., 2021].
Treatment can restore health and well-being, and for many parents it opens the way to family reunification. Anyone concerned about methamphetamine use - their own or a loved one's - should speak with a doctor or a licensed addiction treatment provider about the options that fit their situation.
Frequently Asked Questions
What are common signs that someone may be using methamphetamine?
Common signs include unusual alertness or talkativeness, little need for sleep, rapid weight loss, dilated pupils, jerky movements, skin sores, dental problems, mood swings and paranoia. These signs can have other causes, so a health professional should be involved before drawing conclusions.
What happens during methamphetamine withdrawal?
Withdrawal often brings extreme tiredness, long periods of sleep, increased appetite, depression, anxiety and strong cravings. Symptoms usually ease over days to weeks, but low mood and cravings can last longer, so medical and emotional support during this period lowers the risk of relapse.
Is there a prescription form of methamphetamine?
Yes. A prescription form of methamphetamine is approved in limited cases for attention deficit hyperactivity disorder, at much lower doses and under medical supervision. It is rarely prescribed because of its high potential for misuse and addiction.
Can naloxone reverse a methamphetamine overdose?
Naloxone does not reverse the effects of stimulants such as methamphetamine. However, many stimulant overdoses also involve opioids such as fentanyl, so giving naloxone and calling 911 is still recommended whenever an overdose is suspected.
Where can someone in the United States find help for methamphetamine addiction?
The SAMHSA National Helpline at 1-800-662-4357 offers free, confidential treatment referrals and information 24 hours a day, every day of the year. The FindTreatment.gov locator can also be used to search for treatment programs by location and payment options.
Does methamphetamine use increase the risk of infectious diseases?
Yes. Methamphetamine use is linked to higher rates of HIV and hepatitis B and C, both from shared injection equipment and from impaired judgment that can lead to risky sexual behavior. Testing, sterile supplies and prompt medical care help reduce these risks.
How can family members support a loved one with methamphetamine addiction?
Families can learn about addiction as a medical condition, avoid blame, set clear and safe boundaries and encourage professional treatment. Family counseling and support groups for relatives can also help caregivers manage stress and keep children safe.
Are people with disabilities at higher risk of substance use problems?
People with disabilities can face added risk factors such as chronic pain, social isolation, unemployment and barriers to accessible health care. Accessible treatment programs and providers who understand disability needs help improve recovery outcomes.
References:
- Congressional Research Service. (2008). Methamphetamine: Legislation and issues in the 110th Congress (RS22325).
- Drug Enforcement Administration. (2024). National drug threat assessment 2024. U.S. Department of Justice.
- Garnett, M. F., and Minino, A. M. (2026). Drug overdose deaths in the United States, 2023 - 2024 (NCHS Data Brief No. 549). National Center for Health Statistics.
- National Institute on Drug Abuse. (n.d.-a). What are the long-term effects of methamphetamine misuse? Methamphetamine Research Report.
- National Institute on Drug Abuse. (n.d.-b). What are the risks of methamphetamine misuse during pregnancy? Methamphetamine Research Report.
- National Institute on Drug Abuse. (n.d.-c). What treatments are effective for people who misuse methamphetamine? Methamphetamine Research Report.
- Office of National Drug Control Policy. (2025). 2024 methamphetamine implementation report. Executive Office of the President.
- Otero, C., Boles, S., Young, N. K., and Dennis, K. (2006). Methamphetamine addiction, treatment, and outcomes: Implications for child welfare workers. National Center on Substance Abuse and Child Welfare.
- Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60).
- Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., Rush, A. J., Nunes, E. V., and Shoptaw, S. (2021). Bupropion and naltrexone in methamphetamine use disorder. New England Journal of Medicine, 384(2), 140 - 153.
Insights, Analysis, and Developments
Editorial Note: Methamphetamine has stayed a serious problem for more than two decades because the market kept adapting - when pharmacy limits shut down most home labs, cartel production filled the gap with a purer, cheaper drug. The people who pay the highest price are often the ones with the least say in it, especially children raised in homes where the drug is used or made, and babies exposed before birth. The research also carries a clear message of hope. Behavioral treatments such as contingency management and the Matrix Model do reduce use, the brain can partly heal with long-term abstinence, and treatment gives many parents a real path back to their families. No medication is approved yet, so wider access to proven behavioral care remains one of the most useful steps communities can take.
Author Credentials: Ian C. Langtree is a writer, editor, and the founder and Editor-in-Chief of Disabled World, which he established in 2004 as one of the longest-running independent resources for disability news and information. Over more than two decades, he has written and edited thousands of articles on disability rights, health, accessibility, and assistive technology. Drawing on a global perspective shaped by extensive travel and lived experience, Ian is a committed advocate of the Social Model of Disability, the framework developed by disabled activists in the 1970s that focuses on removing societal barriers rather than on individual impairments. His writing is grounded in that framework and in a lasting commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.